Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) [Original Articles]

Conclusions Compared with chlorthalidone, treatment with lisinopril is not associated with a meaningful reduction in incident AF or AFL among older adults with a history of hypertension. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000542.

http://circep.ahajournals.org/cgi/content/short/10/12/e005463?rss=1

Source: Circulation: Arrhythmia and Electrophysiology - December 6, 2017 Category: Cardiology Authors: Dewland, T. A., Soliman, E. Z., Yamal, J.-M., Davis, B. R., Alonso, A., Albert, C. M., Simpson, L. M., Haywood, L. J., Marcus, G. M., for the ALLHAT Collaborative Research Group Tags: Atrial Fibrillation, ACE/Angiotensin Receptors/Renin Angiotensin System, Epidemiology, Primary Prevention Original Articles Source Type: research